<DOC>
	<DOCNO>NCT01884350</DOCNO>
	<brief_summary>The study purpose assess impact educational program patient adherence patient take Apixaban SPAF 24 week</brief_summary>
	<brief_title>Assessment Education Guidance Programme Eliquis Adherence Non-Valvular Atrial Fibrillation ( AEGEAN )</brief_title>
	<detailed_description>SPAF=Stroke Prevention Atrial Fibrillation ISTH=International Society Thrombosis Hemostasis Primary Purpose : Other : To measure adherence study medication use electronic monitoring device first 24 week study medication</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>1 . Patients diagnose nonvalvular Atrial Fibrillation ( AF ) atrial flutter ( documented 12lead electrocardiogram ( ECG ) Holter record ) eligible oral anticoagulant ( OAC ) therapy 2 . Presence least one follow risk factor stroke : Prior stroke transient ischaemic attack ( TIA ) Age ≥75 year Hypertension Diabetes mellitus Symptomatic heart failure [ New York Heart Association ( NYHA ) Class ≥II ] 3 . Must able selfadminister treatment 4 . Either Vitamin K antagonist ( VKA ) treat VKA naive . Patients treat VKA receive VKA treatment ≥3 month . VKA naïve patient receive VKA treatment 30 day within last 12 month . Patients describe either criterion eligible study 5 . Patients previously treat acetylsalicylic acid ( ASA ) stroke prevention allow ( switch Apixaban ) 6 . Patients screen minimental state examination ( MMSE ) 24 7 . Subject Reenrollment : This study permit reenrollment subject discontinue study pretreatment failure Age Reproductive Status : ) Men woman ≥18 year age ii ) Women childbearing potential ( WOCBP ) must use method ( ) contraception base table protocol . WOCBP must negative serum urine pregnancy test ( minimum sensitivity 25 IU/L equivalent unit HCG ) within 24 hour prior start study medication iv ) Women must breastfeed v ) Men sexually active woman childbearing potential ( WOCBP ) must use contraceptive method failure rate le 1 % per year vi ) Women childbearing potential ( ie , postmenopausal surgically sterile ) ; azoospermic men require contraception 1 . Target Disease Exceptions : 1 . Atrial fibrillation flutter due reversible cause ( e.g . thyrotoxicosis , pericarditis ) 2 . Clinically significant ( moderate severe ) mitral stenosis 3 . Cardiac valvular disease require surgery 4 . Planned major surgery or/and invasive procedure and/or atrial fibrillation flutter , ablation procedure and/or cardioversion 5 . Patients receive Rivaroxaban , Dabigatran Apixaban 2 . Medical History Concurrent Diseases : 1 . Conditions atrial fibrillation require chronic anticoagulation ( e.g. , prosthetic mechanical heart valve , venous thromboembolism ; also see Section 3.4 , Concomitant Treatments ) 2 . Patient serious bleed last 6 month lesion condition high risk bleeding : Active peptic ulcer disease , current recent gastrointestinal ulceration Known suspect esophageal varix Recent ischemic stroke ( within 7 day ) Recent brain spinal injury intracranial hemorrhage Recent brain , spinal ophthalmic surgery Arteriovenous malformation Vascular aneurysm Major intraspinal intracerebral vascular abnormality Documented hemorrhagic tendency blood dyscrasia Presence malignant neoplasms high risk bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>